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underwent percutaneous coronary intervention
of the left anterior descending coronary artery,Figure 1. OCT Representations Post-Procedure and at 12 Months Fo
(DREAMS) Implantation
The dashed lines labeled A, B, C, A0 , B0 , and C0 indicate the locations o
white arrow in B0 indicates a neointimal membranous bridge that partia
yellow arrows in C0 indicate the shadows of the remnants of struts. 12
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sorbable metal scaffold (DREAMS, Biotronik,
Bülach, Switzerland) was successfully implanted.llow-Up After Drug-Eluting Absorbable Metallic Scaffold
f the respective OCT images. Asterisks indicate side branches. The
lly replaced the stent struts overhanging a side branch ostium. The
M ¼ 12 months; Ca ¼ calciﬁed plaque; GWS ¼ guidewire shadow.Post-procedural angiography showed excellent re-
sults without pinching of the side branch ostium.
The patient experienced no procedure-related com-
plications, and was discharged 48 h after the proce-
dure on dual antiplatelet therapy. Optical coherence
tomography (OCT) (LightLab Imaging, Westford,
Massachusetts) was performed post-procedure and
at 12 months follow-up. Post-procedurally, the
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576scaffold was well expanded with good apposition of struts to
the vessel wall, and a side branch was jailed by the struts of
DREAMS (Figs. 1A and 1B). At 12 months follow-up,
OCT showed a smooth luminal surface with moderate
neointimal hyperplasia in the scaffolded segment. Some
remnants of struts were still visible with shadows (Fig. 1C0,
yellow arrows). Interestingly, the struts overhanging a side
branch ostium were partially replaced by a neointimal
membranous bridge (Fig. 1B0, white arrow), whereas
3-dimensional OCT revealed the unobstructed and widely
opened ostium of the side branch.
This is the ﬁrst report to our knowledge of a serial OCT
assessment in a case of overhanging struts at the ostium of
a side branch after DREAMS implantation. Fully bio-
resorbable scaffolds are a novel therapeutic approach
because they provide transient vessel support, in contrast to
the permanent metallic stents. The DREAMS absorbable
metal scaffold is made of a magnesium alloy, and is pro-
grammed to be absorbed and ultimately converted to hy-
droxyapatite 9 to 12 months following implantation (1).
Previously, a similar case had been reported with the
everolimus-eluting polymeric bioresorbable scaffold (Absorb
BVS, Abbott Vascular, Santa Clara, California), but with a
longer period (24 months) of bioresorption than in this case(2). This case highlights the resorption of the magnesium
struts overhanging a side branch ostium, as illustrated in
3-dimensional OCT (3).
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